NANOLEK, OOO, Moscow

Accounting reports

Previously

Contacts

Name	NANOLEK, OOO
INN	7701917006
KPP	770701001
OGRN	1117746339369
OKPO	91523979
Address	127055, G.moskva, ul. Butyrskiy Val, d. D. 68/70, of. ETAZH 2 POM I KOM 23-37
Phone	+7 (499) 250-01-82 Contact details

Extract from EGRUL $12 (€10)

Last name, first name & patronymic of the General Director

List of founders

Position of the company

Licenses

Authorized capital

Branches

Complete structure of the extract

Download an extract from EGRUL

We guarantee to provide you with an actual
information extract

OKVED code	Type	Name of activity type
Data on types of economic activities NANOLEK, OOO according to EGRUL
21.10	Core activity	Manufacture of manmade fibres
21.20.1	Additional activity	Production of drugs
21.20.2	Additional activity	Production of materials used in medical applications
All types of activities
26.60.1	Additional activity	Manufacture of irradiation, electromedical and electrotherapeutic equipment
46.46	Additional activity	Wholesale of pharmaceutical goods
69.10	Additional activity	Legal activities
70.22	Additional activity	Advice on business and management
72.19	Additional activity	Research and experimental development on natural sciences and engineering Other
73.20.1	Additional activity	Market and opinion research

Registration information

Registration date	28.04.2011
Registering department	Mezhrayonnaya inspektsiya Federal'noy nalogovoy sluzhby N 46 po g. Moskve

Description

NANOLEK, OOO (Moscow; INN 7701917006) was registered on 28 Apr 2011. The company's authorized capital as of July 1, 2012 was 1704600000 rub.

Type of ownership of NANOLEK, OOO - Limited liability companies.

Form of ownership of NANOLEK, OOO - Property of foreign legal entities.

Principal activities of NANOLEK, OOO: manufacture of manmade fibres (21.10), production of drugs (21.20.1), production of materials used in medical applications (21.20.2).

Industry

21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
- 21.2 - The production of medicines and materials used in medical purposes
  - 21.20 - Manufacturers of drugs and pharmaceuticals and medical products
    - 21.20.1 - Production of drugs
    - 21.20.2 - Production of materials used in medical applications
- 21.1 - Pharmaceutical substances
  - 21.10 - Manufacture of manmade fibres
26 - Manufacture of computer, electronic and optical products
- 26.6 - Manufacture of irradiation and electrotherapeutic equipment used for medical purposes
  - 26.60 - Manufacture of irradiation and electrotherapeutic equipment used for medical purposes
    - 26.60.1 - Manufacture of irradiation, electromedical and electrotherapeutic equipment
46 - Wholesale trade (excluding motor vehicles)
- 46.4 - Wholesale of household goods
  - 46.46 - Wholesale of pharmaceutical goods
69 - Legal activities
- 69.1 - Activities in the field of law
  - 69.10 - Legal activities
70 - Administration and management of companies and enterprises
- 70.2 - Public relations and business consulting
  - 70.22 - Advice on business and management
72 - Scientific research and development
- 72.1 - Research and experimental development on natural sciences and engineering
  - 72.19 - Research and experimental development on natural sciences and engineering Other
73 - Market and opinion research
- 73.2 - Market research and public opinion polling
  - 73.20 - Market research and public opinion polling
    - 73.20.1 - Market and opinion research

Economic indicators

2023

Net profit (RAS) of NANOLEK, OOO dropped in 2023 2.22 times to 1.11 billion RUB from 2.46 billion RUB over the same period in 2022, the company informed.

Revenue decreased in the accounting period by 4.31% to 18.09 billion RUB from 18.91 billion RUB in 2022; cost of goods sold decreased by 1.30% to 14.39 billion RUB from 14.57 billion RUB; sales profit fell by 19.57% to 2.56 billion RUB from 3.19 billion RUB.

2022

Net profit (RAS) of NANOLEK, OOO grew over 2022 by 7.85% to 2.47 billion RUB from 2.29 billion RUB over 2021, the company informed.

Revenue decreased in the accounting period by 2.45% to 18.91 billion RUB from 19.38 billion RUB in 2021; cost of goods sold decreased by 5.36% to 14.57 billion RUB from 15.40 billion RUB; sales profit went up by 7.87% to 3.19 billion RUB from 2.95 billion RUB.

2021

Net profit (RAS) of NANOLEK, OOO grew over 2021 4.55 times to 2.29 billion RUB from 502.84 million RUB over 2020, the company informed.

Revenue increased in the accounting period 1.57 times to 19.38 billion RUB from 12.35 billion RUB over 2020; cost of goods sold grew 1.51 times to 15.08 billion RUB from 10.00 billion RUB; sales profit went up 2.01 times to 2.95 billion RUB from 1.47 billion RUB.

2020

Net profit (RAS) of NANOLEK, OOO dropped in 2020 by 11.42% to 502.84 million RUB from 567.68 million RUB over the same period in 2019, the company informed.

Revenue increased in the accounting period 1.64 times to 12.35 billion RUB from 7.53 billion RUB over 2019; cost of goods sold grew 1.70 times to 10.00 billion RUB from 5.89 billion RUB; sales profit went up 1.87 times to 1.47 billion RUB from 785.43 million RUB.

2019

Net profit (RAS) of NANOLEK, OOO grew over 2019 4.07 times to 595.81 million RUB from 146.53 million RUB over 2018, the company informed.

Revenue increased in the accounting period 1.76 times to 7.57 billion RUB from 4.29 billion RUB over 2018; cost of goods sold grew 1.88 times to 5.89 billion RUB from 3.13 billion RUB; sales profit went up 1.60 times to 827.42 million RUB from 517.23 million RUB.

2018

Net profit (RAS) of NANOLEK, OOO made up 146.53 million RUB over 2018 compared to net loss of 135.85 million RUB over 2017, the company informed.

Revenue increased in the accounting period 1.76 times to 4.68 billion RUB from 2.66 billion RUB over 2017; cost of goods sold grew 1.54 times to 3.86 billion RUB from 2.50 billion RUB; sales profit made up 180.00 million RUB compared to sales loss of 326.07 million RUB.

2017

Net loss (RAS) of NANOLEK, OOO dropped over 2017 by 44.11% to 135.85 million RUB from 243.09 million RUB KAgent.Entities.Balance, the company informed.

Revenue increased in the accounting period 3.26 times to 2.66 billion RUB from 816.82 million RUB over 2016; cost of goods sold grew 3.25 times to 2.50 billion RUB from 767.71 million RUB; sales loss decreased by 29.18% to 326.07 million RUB from 460.40 million RUB.

2012

Net loss (RA) of Nanolek, OOO made up 54.65 million RUB over 2012 compared to net profit of 725.00 thousand RUB over 2011, the company informed.

Sales loss grew 16.57 times to 96.86 million RUB from 5.85 million RUB.

Financial Highlights

Revenue and earnings data

Daily subscription $39 (€32)

unlimited access to database "Kontragent"

download any information within 24 hours

Pay online

Companies in the region

Guarantees

We guarantee

provision of
relevant
information

Payment methods

Statistics

Companies

12 288 329

Reports

17 430 699

Rrocessed requests

Extract from EGRUL:

Today, 5:57 PM

Accounting reports:

Today, 5:54 PM